M&A Deal Summary

Viatris Acquires Agila Specialties Pvt.

On December 4, 2013, Viatris acquired medical products company Agila Specialties Pvt. from Strides Pharma Science for 1.8B USD

Acquisition Highlights
  • This is Viatris’ 2nd transaction in the Medical Products sector.
  • This is Viatris’ 4th largest (disclosed) transaction.
  • This is Viatris’ 2nd transaction in India.

M&A Deal Summary

Date 2013-12-04
Target Agila Specialties Pvt.
Sector Medical Products
Buyer(s) Viatris
Sellers(s) Strides Pharma Science
Deal Type Divestiture
Deal Value 1.8B USD

Target

Agila Specialties Pvt.

Bengaluru, India
Agila Specialties Private Limited, a developer, manufacturer and marketer of high-quality generic injectable products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Viatris

Canonsburg, Pennsylvania, United States

Category Company
Founded 1961
Sector Life Science
Employees33,000
Revenue 15.4B USD (2023)
DESCRIPTION

Viatris is a generic and specialty pharmaceutical company. Viatris offers the industry's broadest and highest quality product portfolios, a robust product pipeline, and a global commercial footprint through operations in more than 90 countries. Viatris was founded in 1961 and is based in Canonsburg, Pennsylvania.


DEAL STATS #
Overall 6 of 13
Sector (Medical Products) 2 of 3
Type (Divestiture) 2 of 6
Country (India) 2 of 3
Year (2013) 1 of 1
Size (of disclosed) 4 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-09-07 Bioniche Pharma Holdings

Lake Forest, Illinois, United States

Bioniche Pharma Holdings Ltd. is a developer and manufacturer of injectable pharmaceutical products serving a variety of niche markets, including analgesics/anesthetics, orthopedics, oncology, and urology.

Buy $550M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-02-02 Famy Care

Mumbai, India

Famy Care Ltd is a family owned pharmaceutical manufacturer based in India. The company specializes in the women’s healthcare market, specifically contraceptive formulations and devices.

Buy $750M

Seller(S) 1

SELLER

Strides Pharma Science

Bangalore, India

Category Company
Founded 1990
Sector Life Science
Employees2,390
Revenue 40.5B INR (2024)
DESCRIPTION

Strides Pharma Science is a pharmaceutical company. Strides operates in pharma generics, branded generics, and biopharma. Strides Pharma Science was founded in 1990 and is based in Bangalore, India.


DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 1 of 1
Type (Divestiture) 2 of 2
Country (India) 1 of 1
Year (2013) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-01-24 Ascent Pharmahealth

Melbourne, Australia

Ascent Pharmahealth Ltd, markets in Australia, Singapore, Malaysia, Hong Kong, Vietnam, Thailand and other Asian countries with a range of generic pharmaceuticals, consumer skincare and over the-counter (OTC) medicines. Ascent has a regional manufacturing facility located in Singapore which manufactures prescription and OTC products in varied dosage forms for the Southeast Asia market.

Sell AU$375M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-11-25 PediaCare

Staten Island, New York, United States

PediaCare is a provider of products for children, primarily within cough cold and analgesics segments.

Buy $5M